**Strong 2026 IPO momentum, anchored by SpaceX’s record June listing that raised roughly $75 billion, continues to shape trader views on whether additional major companies will complete offerings before year-end 2026.** Through September, traditional U.S. IPO proceeds exceeded $120 billion—already surpassing full-year 2025 totals—with AI, biotech, and infrastructure names driving activity amid elevated risk appetite and supportive equity markets. Anthropic’s confidential S-1 filing and reported plans to market in early November for a potential pre-Thanksgiving debut at a multi-trillion-dollar valuation represent the clearest near-term catalyst, though success hinges on valuation discipline and follow-through from recent deals. OpenAI has signaled a 2027 timeline, while smaller and mid-sized issuers maintain a steady pipeline of S-1 filings and pricings. Key variables for remaining 2026 resolutions include fourth-quarter market volatility, Treasury yields, and performance of headline AI listings; any pullback could push marginal candidates into 2027.